Olon, International API Supplier, Releases New 2022 Sustainability Report

Olon, international API supplier, releases the new Sustainability Report 2022, confirming the progress of its sustainability in the focus areas on environment, supply chain, people, community engagement, production. 

“Our ambition is to promote a more sustainable production of APIs, meeting the highest standards of quality,” Paolo Tubertini, CEO of the Group, commented. “To achieve this, we are investing in people, in innovation and technology processes, endorsing the sustainable development goals proposed by the UN 2030 Agenda.”


Milan, November 21st, 2022 — Olon, international API supplier, is proud to publish the annual Corporate Sustainability Report for 2022, which details the global company commitment to people, planet, and communities in which it operates. The report outlines the substantial progresses achieved in the focus areas - to reduce the footprint on the environment, to create a sustainable global supply chain, to include people diversity, to engage communities and stakeholder, to promote the most advanced and sustainable manufacturing processes.

“After the 2021 publication of our first Sustainability Manifesto, this is a clear statement and policy document representing that we are pursuing our vision of sustainable growth. It is an assumption of responsibility towards customers, partners, and employees. Our vision is to be a global leader in API production from a business, social and ethical perspective. We will continue to introduce new initiatives to deliver our future ambitions,” Paolo Tubertini commented.

The full report is here:

https://olonspa.com/we-are-olon#sustainability

FACTS & FIGURES

To reduce energy consumption, Olon has launched a long-term program to progressively install renewable energy systems in the facilities of global manufacturing network.

Over 2022, the Group has been carrying on investments in 4 out of the 11 Olon sites to install advanced solar panel systems to generate renewable energy. In Rodano, one of the most strategic sites further than HQ base, they have just successfully implemented the installation and the system is running and they have already allocated a significative investment for the next step ahead – a new massive solar system. Thanks to this investment, 15% of the electric energy used in Rodano facility will be covered by renewable source by 2023.

More than the 70% of Olon global purchases comes from suppliers that have formally accepted and signed the Code of Conduct.

OLON ENVIRONMENTAL TARGETS

  • –60% of specific energy consumption per ton of production, from 2018–2025
  • –60% of CO2 emissions from 2018–2025
  • –60% of water consumption to promote fair and sustainable use from 2018–2025
  • –40% of generated waste from 2018–2025
  • +50% of recycled waste on the total waste from 2018–2025

 


About the Company:

Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMOs and generics, a reliable and preferential partner to the pharmaceutical, biotech, and specialty ingredients markets. With a 2021 turnover of $580 million, Olon supplies 300 APIs for the generics market.

Thanks to all the 2,300 employees, and to highly qualified R&D team — more than 300 people — Olon can offer complete integrated packages and services to support the full development of APIs based on strong knowledge of both chemical and biological processes, all of them under a full cGMP and regulatory coverage. Olon is the holder of about 160 active U.S. DMFs and 79 granted CoS.

Headquartered in Rodano (Milan, Italy), Olon has 11 manufacturing facilities — eight located in Italy, one in Spain, one in the USA, and one in India, designed in compliance with the strictest international requirements, and three branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China). Visit us at www.olonspa.com.

Media Contact:

Sabrina Spina

sspina@olonspa.it – mobile 338.6674289

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Olon

Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMOs and generics, a reliable and preferential partner to the pharmaceutical, biotech, and specialty ingredients markets. With a 2021 turnover of $580 million, Olon supplies 300 APIs for the generics market.

Thanks to all the 2,300 employees, and to their highly qualified R&D team — more than 300 people — Olon can offer complete integrated packages and services to support the full development of APIs based on strong knowledge of both chemical and biological processes, all under a full cGMP and regulatory coverage. Olon is the holder of about 160 active U.S. DMFs and 79 granted CoS. 
Headquartered in Rodano (Milan, Italy), Olon has 11 manufacturing facilities — eight located in Italy, one in Spain, one in the USA, and one in India, designed in compliance with the strictest international requirements, and three branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China). 

Q: